Current standard-of-care prophylaxis for DVT includes pharmacological agents such as anticoagulants, and recently, there has been an increase in the use of mechanical medical devices such as sequential compression devices (SCDs). Hospitalization for acute medical illness is an important opportunity for applying prevention efforts. These guidelines address methods to prevent VTE in hospitalized and non-hospitalized medical patients and long-distance travelers. Access the full guidelines on the Blood Advances website: Patients at moderate to high VTE risk should receive intermittent pneumatic compression devices (IPC) and chemical prophylaxis as soon as clinically safe. Hold chemical prophylaxis for a platelet count 50,000/mm3. Interruption of chemical prophylaxis for procedures should be avoided. This article explores DVT prophylaxis and outlines symptoms and treatments for DVT. In response to this, an updated literature search on prophylaxis for medical patients who were hospitalized and those who were not hospitalized was carried out. The purpose of this article is to report the main findings from this updated literature search. Deep Venous Thrombosis Prophylaxis refers to the preventive measures taken to avoid the formation of blood clots in the deep veins, typically in the legs, which can lead to serious health complications. Reassess the score throughout hospitalization, as new risk factors (e.g., central venous catheter placement, infection requiring IV antibiotics, prolonged immobility) can add points and change prophylaxis decisions. Treatment to prevent deep venous thrombosis is required for patients who are bedbound with major illness and/or those undergoing certain surgical procedures. Early mobilization, leg elevation, and an anticoagulant are the recommended preventive measures; patients who should not receive anticoagulants may benefit from intermittent pneumatic compression devices or elastic stockings. In such trials, participants with asymptomatic DVT were usually treated with therapeutic anticoagulation, thus artificially reducing the risk of developing symptomatic DVT or PE. Venous thromboembolism (VTE) prophylaxis consists of pharmacologic and nonpharmacologic measures to diminish the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE).